176 related articles for article (PubMed ID: 22280244)
1. Identification of a biomarker panel for colorectal cancer diagnosis.
García-Bilbao A; Armañanzas R; Ispizua Z; Calvo B; Alonso-Varona A; Inza I; Larrañaga P; López-Vivanco G; Suárez-Merino B; Betanzos M
BMC Cancer; 2012 Jan; 12():43. PubMed ID: 22280244
[TBL] [Abstract][Full Text] [Related]
2. Detecting reliable gene interactions by a hierarchy of Bayesian network classifiers.
Armañanzas R; Inza I; Larrañaga P
Comput Methods Programs Biomed; 2008 Aug; 91(2):110-21. PubMed ID: 18433926
[TBL] [Abstract][Full Text] [Related]
3. [Identification of colorectal cancer, adenoma, and inflammatory bowel disease specific gene expression patterns using whole genomic oligonucleotide microarray system].
Galamb O; Gyorffy B; Sipos F; Spisák S; Németh AM; Miheller P; Dinya E; Molnár B; Tulassay Z
Orv Hetil; 2007 Nov; 148(44):2067-79. PubMed ID: 17959550
[TBL] [Abstract][Full Text] [Related]
4. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
[TBL] [Abstract][Full Text] [Related]
6. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.
Rodia MT; Ugolini G; Mattei G; Montroni I; Zattoni D; Ghignone F; Veronese G; Marisi G; Lauriola M; Strippoli P; Solmi R
Oncotarget; 2016 May; 7(21):30295-306. PubMed ID: 26993598
[TBL] [Abstract][Full Text] [Related]
7. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer.
Kwon HC; Kim SH; Roh MS; Kim JS; Lee HS; Choi HJ; Jeong JS; Kim HJ; Hwang TH
Dis Colon Rectum; 2004 Feb; 47(2):141-52. PubMed ID: 15043283
[TBL] [Abstract][Full Text] [Related]
9. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
10. A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia.
Yip KT; Das PK; Suria D; Lim CR; Ng GH; Liew CC
J Exp Clin Cancer Res; 2010 Sep; 29(1):128. PubMed ID: 20846378
[TBL] [Abstract][Full Text] [Related]
11. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
12. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
[TBL] [Abstract][Full Text] [Related]
13. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
[TBL] [Abstract][Full Text] [Related]
14. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
15. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
[TBL] [Abstract][Full Text] [Related]
16. Introducing a novel and robust technique for determining lymph node status in colorectal cancer.
Hogan J; Judge C; O'Callaghan M; Aziz A; O'Connor C; Burke J; Dunne C; Walsh S; Kalady M; Coffey JC
Ann Surg; 2014 Jul; 260(1):94-102. PubMed ID: 24169164
[TBL] [Abstract][Full Text] [Related]
17. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
[TBL] [Abstract][Full Text] [Related]
19. Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.
Shivakumar BM; Rotti H; Vasudevan TG; Balakrishnan A; Chakrabarty S; Bhat G; Rao L; Pai CG; Satyamoorthy K
World J Gastroenterol; 2015 Jan; 21(2):616-22. PubMed ID: 25605985
[TBL] [Abstract][Full Text] [Related]
20. The potential role of microRNA-31 expression in early colorectal cancer.
Tateishi Y; Okudela K; Mitsui H; Umeda S; Suzuki T; Kojima Y; Watanabe K; Kawano N; Endo I; Ohashi K
Pathol Int; 2015 Oct; 65(10):513-8. PubMed ID: 26173758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
